• ქართული
  • English
  • Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal

    Thermo Fisher Scientific Inc said on Tuesday it agreed to acquire German genetic testing company Qiagen NV in an $11.5 billion deal as the U.S.-based company looks to bolster its health diagnostic business.

    Market Quotes by TradingView